Utilization and related harms of systemic glucocorticosteroids for atopic dermatitis: claims data analysis
- Published on 07/29/2024
- Reading time: 4 min.
Kristina Hagenström, Theresa Klinger, Katharina Müller, Charlotte Willers, Matthias Augustin
Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
Corresponding author: Kristina Hagenström, Email:k.hagenstroem@uke.de
Abstract
Background and objectives Systemic glucocorticosteroids (SGCs) are used in the short-term treatment of atopic dermatitis (AD), but are not recommended for long-term use since associated with severe side effects. This study aimed to characterize the utilization and potentially negative effects of SGC use for AD in German statutory health insurance (SHI) claims data.
Patients and methods Cross-sectional and longitudinal analysis of a large nationwide SHI...
To continue reading this article in Full-Text...
Peer-Reviewed Journals A-Z
Search | Advanced search
Get the latest news in Dermatology
Receive our newsletter to stay up to date with the latest news in Dermatology
